In Vivo Metabolic Profiling of Equisetum debile Roxb . in Rats Based on High‐Resolution Mass Spectrometry
Biomedical Chromatography · 2026-07 · 40 (7)
DOI: 10.1002/bmc.70504 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 03.06.2026. Verfasst von Chunyan Zhu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Fujian Provincial Key Laboratory of Innovative Drug Target Research and State Key Laboratory of Cell Stress Biology, School of Pharmaceutical Science…. Hauptthemen laut MEDLINE: Equisetum, Metabolome, Liquid Chromatography-Mass Spectrometry, Metabolomics. Die Arbeit nennt 23 Literaturangaben. Gefördert von: the Xiamen Medical and Health Key Projects, Postdoctoral Fellowship Program (Grade B) of China Postdoctoral Science Foundation, Science and Technology Projects of Fujian Province.
Abstract (Originalsprache)
Equisetum debile Roxb . ( E . debile ) is a traditional Chinese medicinal herb widely used for its diuretic, heat‐clearing, and analgesic properties. Although increasing evidence has demonstrated its lipid‐regulating, antioxidant, and anti‐inflammatory activities, its in vivo metabolic profile and pharmacologically active constituents remain insufficiently characterized, limiting clinical application. In this study, UPLC‐HRMS combined with advanced high‐resolution mass spectrometry data processing was employed to systematically characterize the chemical constituents of E. debile and to investigate its absorption, distribution, metabolism, and excretion (ADME) in rats. E. debile was found to contain abundant organic acids, flavonoids, amino acids, and glycosides. Importantly, organic acids and flavonoid glycosides exhibited relatively high systemic exposure, suggesting their potential contribution as key in vivo bioactive constituents. Metabolic analyses revealed that flavonoids undergo oxidation, methylation, glucuronidation, and glutathione conjugation, whereas organic acids are primarily metabolized via decarboxylation and sulfation. In addition, several metabolites preferentially accumulated in bile, indicating the involvement of enterohepatic circulation. Overall, this study provides the first comprehensive and mechanistically informed characterization of the in vivo–exposed constituents and metabolic transformations of E. debile in rats, offering critical insights for its pharmacokinetic evaluation, mechanism of action studies, and modern clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fujian Provincial Key Laboratory of Innovative Drug Target Research and State Key Laboratory of Cell Stress Biology, School of Pharmaceutical Sciences, Xiamen University, Xiamen, China.
- Xiamen Key Laboratory for Clinical Efficacy and Evidence-Based Research of Traditional Chinese Medicine, Xiamen University, Xiamen, China.
ORCID-Profile: Caisheng Wu
Förderung
- the Xiamen Medical and Health Key Projects
- Postdoctoral Fellowship Program (Grade B) of China Postdoctoral Science Foundation
- Science and Technology Projects of Fujian Province
Zitieren
APA
Zhu, C., Yang, Y., Xarpidin, B., Zhang, D., He, S., Wei, C., Tian, W., Chen, H., & Wu, C. (2026). In Vivo Metabolic Profiling of Equisetum debile Roxb . in Rats Based on High‐Resolution Mass Spectrometry. Biomedical Chromatography, 40(7). https://doi.org/10.1002/bmc.70504
Vancouver
Zhu C, Yang Y, Xarpidin B, Zhang D, He S, Wei C, et al. In Vivo Metabolic Profiling of Equisetum debile Roxb . in Rats Based on High‐Resolution Mass Spectrometry. Biomedical Chromatography. 2026;40(7). doi:10.1002/bmc.70504
BibTeX
@article{Zhu2026,
author = {Zhu, Chunyan and Yang, Yuexin and Xarpidin, Bahriman and Zhang, Dandan and He, Shuhan and Wei, Chenyang and Tian, Wenjing and Chen, HaiFeng and Wu, Caisheng},
title = {In Vivo Metabolic Profiling of Equisetum debile Roxb . in Rats Based on High‐Resolution Mass Spectrometry},
journal = {Biomedical Chromatography},
year = {2026},
volume = {40},
number = {7},
doi = {10.1002/bmc.70504}
}
EUVIMED